4//SEC Filing
Wyant Alyssa 4
Accession 0001127602-18-025366
CIK 0001472091other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:55 AM ET
Size
5.4 KB
Accession
0001127602-18-025366
Insider Transaction Report
Form 4
Wyant Alyssa
SVP Regulatory Affairs
Transactions
- Award
Restricted Stock Units
2018-08-14+49,766→ 49,766 total→ Common Stock (49,766 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Edge common stock upon the vesting of such unit.
- [F2]These restricted stock units shall become exercisable upon the achievement of certain performance or time based criteria.
- [F3]Expiration date is not applicable as the vested restricted stock units shall be settled on the first business day following the date that such restricted stock units vest.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001698765
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 7:55 AM ET
- Size
- 5.4 KB